Life Science Reagents Market Size 2019 - 2026 with Rising Trends

Life Science Reagents Market (By Product: Molecular Diagnostic, Chromatograph, Flow Cytometry Cell & Tissue Culture, Microbiology, Immunoassay, Clinical Chemistry, Hematology & Hemostasis, Others; By End User: Commercial, Hospitals & Diagnostics Laboratories, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Life Science Reagents Market Size is Projected to Reach US$ 69 Billion by 2026 and is expected to witness 7.4% CAGR during the forecast period 2019 to 2026.

In the production and testing of pharmaceuticals, cell-based products and several other health alternatives, life science reagents play a critical part. The development of the worldwide market for life sciences is due to the rise in the worldwide geriatric population, which is more likely to suffer from distinct kinds of infectious illnesses. In addition, the development in the worldwide life-science reagents market is boosting incidences of infectious disease and technological developments in the life sciences sector.

In 2018, North America dominated the world’s market for life science reagents, and this trend will remain in the forecast period as well. This is ascribed to the increased research and development operations in the region, which drive a number of research operations to demand for life science reagents.

The rise in local producers, however, which creates price stress on the market is likely to hamper the development of North America’s worldwide life science industry during the latter half of the predicted era. In the forecast period, Asia Pacific is anticipated to be a extremely profitable market for life science reagents.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1464

Market Drivers

In the fields of life sciences and biotechnology, the technological advances have resulted in numerous changes in the areas of health diagnostics, medication discovery, personalized medicines, forensics, and clinical research and development, driving the growth of the reactives market.

The worldwide market for life science reagents is being driven by developments in enzyme-linked immune assay (ELISA), polymerase chain reaction (PCR) technology like digital PCR, rtPCR, chromatography, single cell technology, Next-generation sequencing (NGS) and flow cytometry techniques.

Furthermore, in-vitro diagnostics are one of the major applications of diagnosis for infectious and chronic diseases. In all of the diagnostic tests, life science reagents (biological as well as chemical reagent) are integral and essential.

The in vitro diagnosis sector was favorably affected by the outbreak of infectious viruse such as Zika in 2015. As a result, demand for life sciences reactives has risen.

Regional Stance

Geographically, the worldwide market for life science reagents has been divided into five key areas: North America, Europe, Asia-Pacific, the Middle East and Africa. North America, followed by Europe, dominated the world market for life sciences reagents in 2018. Due to the elevated research and development operations in the region, the region accounted for a significant share of the worldwide life science reagents market in 2018.

From 2019 to 2026, the market for Life Sciences Reagents in Asia Pacific will grow at a high level of CAGR. The rise in health care and in big patient populations, notably in nations such as India and China in the area, can be ascribed to this.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/life-science-reagents-market

Key Players & Strategies

The market of life science reagents is divided and the intensity of competition in the landscape is increasing. The market is extremely controlled by the top actors –F. Hoffmann-La Roche, Abbott, Thermo Fisher Scientific, Inc. Both organic and inorganic approaches are employed by these firms for their place on the market for life sciences reagents. As their organic growth policies, research and development have provided them with the focus for the diversification of their product portfolios. Other players are Beckman Coulter, Inc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BD, bioMérieux SA, Merck KGaA, PerkinElmer Inc., Lonza Bioscience, more.

However, Local players concentrate on providing their international competitors relative cost-effective products. The product offering has helped local players with a widespread supply network in many geographies at comparatively reduced prices than average selling prices. The availability of products at competitive rates has pressured top players, which intensifies competition in the landscape of life sciences.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Life Science Reagents
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Life Science Reagents Market By Product
1.2.2.1. Global Life Science Reagents Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Life Science Reagents Market Revenue Share By Product in 2017
1.2.2.3. Molecular Diagnostic
1.2.2.4. Chromatography
1.2.2.5. Flow Cytometry
1.2.2.6. Cell & Tissue Culture
1.2.2.7. Microbiology
1.2.2.8. Immunoassay
1.2.2.9. Clinical Chemistry
1.2.2.10. Hematology & Hemostasis
1.2.2.11. Others
1.2.3. Life Science Reagents Market By End User
1.2.3.1. Global Life Science Reagents Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.3.2. Global Life Science Reagents Market Revenue Share By End User in 2017
1.2.3.3. Commercial
1.2.3.4. Hospitals & Diagnostics Laboratories
1.2.3.5. Research Institutes
1.2.3.6. Others
1.2.4. Life Science Reagents Market by Geography
1.2.4.1. Global Life Science Reagents Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Life Science Reagents Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Life Science Reagents Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Life Science Reagents Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Life Science Reagents Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Life Science Reagents Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Life Science Reagents Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Life Science Reagents Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Life Science Reagents Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Life Science Reagents Major Manufacturers in 2017

CHAPTER 4. LIFE SCIENCE REAGENTS MARKET BY PRODUCT

4.1. Global Life Science Reagents Revenue By Product
4.2. Molecular Diagnostic
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Chromatography
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Flow Cytometry
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Cell & Tissue Culture
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Microbiology
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Immunoassay
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.8. Clinical Chemistry
4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.9. Hematology & Hemostasis
4.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.10. Others
4.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. LIFE SCIENCE REAGENTS MARKET BY END USER

5.1. Global Life Science Reagents Revenue By End User
5.2. Commercial
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Hospitals & Diagnostics Laboratories
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Research Institutes
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. NORTH AMERICA LIFE SCIENCE REAGENTS MARKET BY COUNTRY

6.1. North America Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Life Science Reagents Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 7. EUROPE LIFE SCIENCE REAGENTS MARKET BY COUNTRY

7.1. Europe Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC LIFE SCIENCE REAGENTS MARKET BY COUNTRY

8.1. Asia-Pacific Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 9. LATIN AMERICA LIFE SCIENCE REAGENTS MARKET BY COUNTRY

9.1. Latin America Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 10. MIDDLE EAST LIFE SCIENCE REAGENTS MARKET BY COUNTRY

10.1. Middle East Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 11. AFRICA LIFE SCIENCE REAGENTS MARKET BY COUNTRY

11.1. Africa Life Science Reagents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Africa Life Science Reagents Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. F. Hoffmann-La Roche
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Abbott
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Thermo Fisher Scientific, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Beckman Coulter, Inc
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Agilent Technologies, Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Bio-Rad Laboratories, Inc
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. BD
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. bioMérieux SA
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Merck KGaA
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. PerkinElmer Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Lonza Bioscience
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1464

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.